Cellid Co. Ltd (299660) - Total Liabilities

Latest as of September 2025: ₩33.79 Billion KRW ≈ $22.90 Million USD

Based on the latest financial reports, Cellid Co. Ltd (299660) has total liabilities worth ₩33.79 Billion KRW (≈ $22.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Cellid Co. Ltd cash flow conversion to assess how effectively this company generates cash.

Cellid Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Cellid Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Cellid Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Cellid Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Cellid Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Brompton Lifeco Split Corp TO:LCS	Canada	CA$73.75 Million
A SPAC II Acquisition Corp. Ordinary Shares NASDAQ:ASCB	USA	$7.26 Million
Beijing North Star Company Limited F:BJ3	Germany	€34.01 Billion
Makarony Polskie S.A. WAR:MAK	Poland	zł67.38 Million
Thermaltake Technology Co Ltd TWO:3540	Taiwan	NT$4.12 Billion
OnMobile Global Limited NSE:ONMOBILE	India	Rs3.34 Billion
Ilji Technology Co. Ltd KQ:019540	Korea	₩460.54 Billion
Chemfab Alkalis Limited NSE:CHEMFAB	India	Rs1.88 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Cellid Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cellid Co. Ltd (299660) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cellid Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cellid Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Cellid Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩24.88 Billion ≈ $16.86 Million	+6.22%
2023-12-31	₩23.43 Billion ≈ $15.88 Million	+0.04%
2022-12-31	₩23.42 Billion ≈ $15.87 Million	+20.12%
2021-12-31	₩19.50 Billion ≈ $13.21 Million	+826.53%
2020-12-31	₩2.10 Billion ≈ $1.43 Million	+77.41%
2019-12-31	₩1.19 Billion ≈ $803.76K	+64.58%
2018-12-31	₩720.63 Million ≈ $488.36K	-93.13%
2017-12-31	₩10.49 Billion ≈ $7.11 Million	+161.36%
2016-12-31	₩4.01 Billion ≈ $2.72 Million	+114.39%
2015-12-31	₩1.87 Billion ≈ $1.27 Million	--

About Cellid Co. Ltd

KQ:299660 Korea Biotechnology

Market Cap

$63.58 Million

₩93.82 Billion KRW

Market Cap Rank

#20952 Global

#1292 in Korea

Share Price

₩3180.00

Change (1 day)

-1.55%

52-Week Range

₩2315.00 - ₩8890.00

All Time High

₩127128.20